Wang, Y., Yan, Y., Shan, D., Chen, J., Liu, W., Wang, T., . . . Yi, S. (2025). Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma. Cancer Biology & Medicine, 22(2), 177. https://doi.org/10.20892/j.issn.2095-3941.2024.0200
Chicago-referens (17:e uppl.)Wang, Yi, et al. "Continuous R-DA-EDOCH Alternated with High-dose Ara-C Induces Deep Remission and Overcomes High-risk Factors in Young Patients with Newly Diagnosed Mantle Cell Lymphoma." Cancer Biology & Medicine 22, no. 2 (2025): 177. https://doi.org/10.20892/j.issn.2095-3941.2024.0200.
MLA-referens (9:e uppl.)Wang, Yi, et al. "Continuous R-DA-EDOCH Alternated with High-dose Ara-C Induces Deep Remission and Overcomes High-risk Factors in Young Patients with Newly Diagnosed Mantle Cell Lymphoma." Cancer Biology & Medicine, vol. 22, no. 2, 2025, p. 177, https://doi.org/10.20892/j.issn.2095-3941.2024.0200.
